deltatrials
Completed NA NCT00002174

Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

Sponsor: Louisiana State University Health Sciences Center in New Orleans

Conditions HIV Infections
Interventions Thalidomide
Updated 5 times since 2017 Last updated: Jun 23, 2005

Listed as NCT00002174, this NA trial focuses on HIV Infections and remains completed. Sponsored by Louisiana State University Health Sciences Center in New Orleans, it has been updated 5 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Louisiana State University Health Sciences Center in New Orleans
Data source: NIH AIDS Clinical Trials Information Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New Orleans, United States